Insulin Aspart Protamine and Insulin Aspart

Novo Nordisk Pharma, Inc.🇺🇸 United States

FDA Page

Effective Date: Feb 28, 2023
Approval ID: fc94baa4-3606-48bc-a781-9617ab6960ef
Products: 2 registered
Version: 8

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 safely and effectively. See full prescribing information for INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30. INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 injectable suspension, for subcutaneous useInitial U.S. Approval: 2001This product is NovoLog Mix 70/30 (insulin aspart protamine and insulin aspart).

Quick Stats

Total Products2

Labelers2

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.